Literature DB >> 15507209

Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function.

Venkat S R K Yedavalli1, Christine Neuveut, Ya-Hui Chi, Lawrence Kleiman, Kuan-Teh Jeang.   

Abstract

A single transcript in its unspliced and spliced forms directs the synthesis of all HIV-1 proteins. Although nuclear export of intron-containing cellular transcripts is restricted in mammalian cells, HIV-1 has evolved the viral Rev protein to overcome this restriction for viral transcripts. Previously, CRM1 was identified as a cellular cofactor for Rev-dependent export of intron-containing HIV-1 RNA. Here, we present evidence that Rev/CRM1 activity utilizes the ATP-dependent DEAD box RNA helicase, DDX3. We show that DDX3 is a nucleo-cytoplasmic shuttling protein, which binds CRM1 and localizes to nuclear membrane pores. Knockdown of DDX3 using either antisense vector or dominant-negative mutants suppressed Rev-RRE-function in the export of incompletely spliced HIV-1 RNAs. Plausibly, DDX3 is the human RNA helicase which functions in the CRM1 RNA export pathway analogously to the postulated role for Dbp5p in yeast mRNA export.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507209     DOI: 10.1016/j.cell.2004.09.029

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  270 in total

1.  Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production.

Authors:  Souad Naji; Géza Ambrus; Peter Cimermančič; Jason R Reyes; Jeffrey R Johnson; Rebecca Filbrandt; Michael D Huber; Paul Vesely; Nevan J Krogan; John R Yates; Andrew C Saphire; Larry Gerace
Journal:  Mol Cell Proteomics       Date:  2011-12-15       Impact factor: 5.911

2.  DDX3 regulates cell growth through translational control of cyclin E1.

Authors:  Ming-Chih Lai; Wen-Cheng Chang; Sheau-Yann Shieh; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2010-09-13       Impact factor: 4.272

3.  HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells.

Authors:  Sonja I Gringhuis; Michiel van der Vlist; Linda M van den Berg; Jeroen den Dunnen; Manja Litjens; Teunis B H Geijtenbeek
Journal:  Nat Immunol       Date:  2010-04-04       Impact factor: 25.606

4.  Bypassing of stems versus linear base-by-base inspection of mammalian mRNAs during ribosomal scanning.

Authors:  Irina S Abaeva; Assen Marintchev; Vera P Pisareva; Christopher U T Hellen; Tatyana V Pestova
Journal:  EMBO J       Date:  2010-11-26       Impact factor: 11.598

Review 5.  RNA helicases: emerging roles in viral replication and the host innate response.

Authors:  Arnaz Ranji; Kathleen Boris-Lawrie
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

Review 6.  Translation initiation of the HIV-1 mRNA.

Authors:  Théophile Ohlmann; Chloé Mengardi; Marcelo López-Lastra
Journal:  Translation (Austin)       Date:  2014-10-31

7.  Proteomic analysis of human hepatoma cells expressing methionine adenosyltransferase I/III: Characterization of DDX3X as a target of S-adenosylmethionine.

Authors:  Paul C Schröder; Joaquín Fernández-Irigoyen; Emilie Bigaud; Antonio Serna; Rubén Renández-Alcoceba; Shelly C Lu; José M Mato; Jesús Prieto; Fernando J Corrales
Journal:  J Proteomics       Date:  2012-01-16       Impact factor: 4.044

8.  The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes.

Authors:  Johanie Charbonneau; Karine Gendron; Gerardo Ferbeyre; Léa Brakier-Gingras
Journal:  RNA       Date:  2012-01-27       Impact factor: 4.942

9.  An unbiased proteomics approach to identify human cytomegalovirus RNA-associated proteins.

Authors:  Erik M Lenarcic; Benjamin J Ziehr; Nathaniel J Moorman
Journal:  Virology       Date:  2015-03-09       Impact factor: 3.616

10.  DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids.

Authors:  Haifeng Wang; Seahee Kim; Wang-Shick Ryu
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.